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Signalling nucleotides are key molecules that help bacteria to rapidly coordi-
nate cellular pathways and adapt to changes in their environment. During
the past 10 years, the nucleotide signalling field has seen much excitement,
as several new signalling nucleotides have been discovered in both eukary-
otic and bacterial cells. The fields have since advanced quickly, aided by the
development of important tools such as the synthesis of modified nucleotides,
which, combined with sensitive mass spectrometry methods, allowed for the
rapid identification of specific receptor proteins along with other novel
genome-wide screening methods. In this review, we describe the principle
concepts of nucleotide signalling networks and summarize the recent work
that led to the discovery of the novel signalling nucleotides. We also highlight
current approaches applied to the research in the field as well as resources and
methodological advances aiding in a rapid identification of nucleotide-specific
receptor proteins.
This article is part of the themed issue ‘The new bacteriology’.1. The principles of nucleotide signalling molecules and
networks
Nucleotide signalling molecules play key roles in the control of cellular pathways
in all domains of life. While we focus in this article on recent advances in the
bacterial nucleotide signalling field, particularly on methodological innovations,
the original concept of a nucleotide as signalling molecule originated in the 1950s
from the investigation on the adrenaline receptor and its signal transduction
network in eukaryotic cells [1–3]. Our current thinking of how signalling nucleo-
tides function is still based on this original concept and putting it into the
framework of bacterial cells can be formulated as follows: bacteria are constantly
exposed to a changing environment, and in order to survive, cells must be able to
detect these changes and rapidly transmit a signal to coordinate an appropriate
cellular response; among other signals, changes in the levels of specific signalling
nucleotides play an important role in this adaptation. As is discussed below, a
number of different signalling nucleotides have now been uncovered; these are
produced and degraded bydedicated enzymes,which in the case of cyclic nucleo-
tides (which many signalling nucleotides are) are so-called cyclase and
phosphodiesterase or hydrolase enzymes (figure 1). The cellular levels of each
signalling nucleotide depend on the combined activity and net output of the
enzymes responsible for their synthesis and degradation. Environmental changes
and stimuli can be sensed directly by the nucleotide synthesizing or degrading
enzymes and alters their activity or by dedicated sensory proteins,which transmit
the signal to the respective cyclase andhydrolase enzymes to adjust their activities
(figure 1). The changes in the cellular level of the signalling nucleotide are then
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Figure 1. Schematic of nucleotide signalling pathway in bacteria. An input
signal is sensed by a dedicated sensor protein or directly by the cyclase or
hydrolase enzymes. This will result in their activating or inhibiting and as
a consequence lead to a change in the intracellular signalling nucleotide con-
centration. At high signalling nucleotide levels, the molecule will bind (i) to
nucleotide-specific riboswitches to affect the transcription or translation of
downstream effector proteins or (ii) to specific receptor proteins and either
directly alter their function or (iii) allow them to interact with specific down-
stream effector proteins. The final output of this will be the activation or
repression of specific cellular pathways, which depending on the signalling
nucleotide and to name a few examples can range from c-di-GMP controlling
flagella, pili and expolysaccaride production, to the stringent response alar-
mones (p)ppGpp diverting resources away from active growth to amino
acid synthesis in order to promote cell survival under starvation conditions.
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ent conformations in the nucleotide-bound state and the
unbound state (figure 1). The receptor proteins themselves
can function as output or so-called effector proteins and have
different activities in the nucleotide-bound and unbound
form (figure 1). Alternatively, the receptor proteins can further
transmit the signal by interacting with downstream effector
proteins to alter their activity (figure 1). More detailed infor-
mation on pathways controlled by diverse bacterial signalling
molecules can be found in a number of recent reviews
[4–11]. In place of binding to specific receptor proteins, there
are now many examples where signalling molecules can also
bind to specific RNA structures, called riboswitches, and in
this manner affect the transcription or translation of a down-
stream gene (figure 1) [12–16]. As discussed in a later
section, conformational changes in riboswitches and receptor
proteins upon signalling molecule binding make them useful
tools for the construction of biosensors allowing the detection
of specific signalling nucleotides in living cells. A key charac-
teristic of such a signal transduction network is that one
signalling molecule can control and coordinate multiple cellu-
lar pathways, such as coordination of flagella versus pili
motility by cyclic-di-guanosine monophosphate (c-di-GMP)or repression of ribosomal and tRNA synthesis genes and
activation of amino acid transport and synthesis genes by the
stringent response signalling nucleotides guanosine tetrapho-
sphate (ppGpp) and guanosine pentaphosphate (pppGpp).
A key in providing a better understanding of the function of
a signalling nucleotide and the network it controls lies with
the identification of the specific receptor and effector proteins.
In the final section of this review, we discuss current
approaches that have aided in the rapid identification of
novel receptor proteins, often on a genome-wide level.
It should, however, also be noted that the outlined concept is
a somewhat simplified view of howa signalling nucleotide net-
work functions. The ability of signalling nucleotides to
function on a local level (right at the spot where they are syn-
thesized) rather than at a cell-wide level is a concept that is
discussed in more detail in another article in this issue [17].2. Recent work leading to the discovery of new
signalling nucleotides
More than a handful of different signalling nucleotides have now
been detected in bacteria and their precise chemical structures
elucidated (figure 2). Depending on the bacterial species, differ-
ent signalling nucleotides are produced and it is clear that
bacteria usually produce a multiplicity of them simultaneously.
The starting building blocks of signalling nucleotides are
usually the nucleotides ATP and GTP, and signalling mol-
ecules are often cyclic mononucleotides (figure 2a) or cyclic
dinucleotides (figure 2c). The first signalling nucleotide ident-
ified in eukaryotic cells in 1958 and a few years afterwards in
bacterial cells was the molecule cyclic adenosine monophos-
phate (cAMP; figure 2a) [2,3,18]. More specifically, the
molecule identified at that time was 30,50-cAMP where the
phosphate group is linked to hydroxyl groups attached to
the 30 and 50 carbon residues within the ribose moiety of ade-
nosine (figure 2a). Knowing the precise chemical structure of
the nucleotide is important, as different nucleotide isoforms
exist and these have different downstream effects and are pro-
duced and degraded by a different set of enzymes. Such
differences in the production and effects between isoforms of
signalling nucleotides have recently gained increased atten-
tion [19–21]. The second signalling nucleotide identified in
bacteria in 1969 was a molecule originally referred to as
‘magic spot’, which was shown in 1970 to be a mixture of
the two signalling nucleotides guanosine tetraphosphate
(ppGpp) and guanosine pentaphosphate (pppGpp;
figure 2b) [22–24]. These two nucleotides are often collectively
referred to as stringent response signalling nucleotides,
although recent work has indicated that ppGpp and
pppGpp can have distinct functions and different effects on
the regulation of cellular signalling processes [25]. In a recent
report, experimental evidence for yet another version of a
stringent response nucleotide, pGpp, was presented [26].
The bacterial nucleotide signalling field gained renewed inter-
est during the 1990s shortly after the discovery of the cyclic
dinucleotide c-di-GMP in 1987 (figure 2c) [27] (and see also
reviews [9–11]). What attracted many researchers to this
field at that point was the great complexity of this system
(see review [28]). In contrast to the previously studied
30,50-cAMP and (p)ppGpp nucleotide systems, in which in
the bacteria studied at that time only a few enzymes are
responsible for their synthesis or degradation, a large
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Figure 2. Chemical structures of (a) cyclic mononucleotide signalling molecules, (b) stringent response signalling nucleotides and (c) cyclic di-nucleotide signalling
molecules.
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degrading c-di-GMP were identified in a single bacterium,
such as Escherichia coli, Pseudomonas aeruginosa or Caulobacter
crescentus to name a few well-studied organisms (see also
review [28]). The next novel signalling nucleotide, cyclic di-
adenosine monophosphate (c-di-AMP), was discovered in
2008 (figure 2c) [29]. This was followed shortly afterwards
by the identification of the cyclic AMP–GMP (cGAMP)
hybrid molecules (figure 2c), first in bacteria in 2012 and
subsequently in eukaryotic cells in 2013 [30–33]. Shortly
after the identification of these hybrid cyclic di-nucleotide
molecules, it was recognized that the bacterial and eukaryotic
molecules are not identical but rather isoforms, with bacteria
producing a 30,30-cGAMP and eukaryotic cells producing a
30,20-cGAMP molecule (figure 2c) [19–21]. Recent work hasalso confirmed that the signalling molecule 30,50-cyclic guano-
sine monophosphate (30,50-cGMP; figure 2a), long known to
exist in eukaryotic cells, is also produced by bacteria such as
Rodospirillum centenum and the plant pathogen Xanthomonas
campestris [34,35]. Finally, several reports have described
20,30-cGMP and 20,30-cAMP isoforms of the classic 30,50 cyclic
mononucleotides in eukaryotic cells (figure 2a) [36,37]. In
addition, 20,30-cCMP and 20,30-cUMP nucleotides were also
reported to be present in eukaryotic cells [38,39], and all
these 20,30-cNMP are, at least in eukaryotic cells, thought to
be produced during the RNA degradation process [40]. How-
ever, the exact functions of such 20,30-cNMP nucleotides and in
particular if they also play a role as signallingmolecules in bac-
terial cells have yet to be established. The discoveries of a
number of novel nucleotide signalling molecules during the
rstb.roya
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number of new researchers and sparked renewed interest in
the two classic bacterial signalling nucleotides 30,50-cAMP
and (p)ppGpp.lsocietypublishing.org
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of nucleotide signalling molecules
One important aspect in the field is the accurate detection
and quantification of signalling nucleotides. For this, liquid
chromatography coupled to mass spectrometry (LC–MS/MS)
is currently the most widely used method [41,42]. In this
approach, complete bacterial metabolite extracts are separated
by LC, and the nucleotides of interest are detected based
on theirmass, and for amore accurate assignment, by their frag-
mentation pattern [42]. Signalling nucleotides within bacterial
cells are often present in very small quantities, and hence the
development of improved mass spectrometry equipment with
better sensitivity increased the utility of this method for the
bacterial nucleotide signalling field. Nucleotides with similar
chromatographic behaviour, which can be isolated using the
same metabolite extraction procedure, can be detected by this
method simultaneously in a single run. An important issue
for the detection and quantification of nucleotides in bacterial
extracts is the use of an appropriate method for the preparation
of the bacterial metabolite extracts. Some nucleotides are very
labile and can be easily degraded during the preparation of
the extracts or do not tolerate the heating step that often
forms part of the extraction procedure. The concentration of a
specific nucleotide within a bacterial extract can be quantified
by comparing its signal intensity with that obtained from
standards of known concentration and for the most accurate
quantification extracts are spiked with a known concentration
of a non-radioactive heavy isotope-labelled version of the sig-
nalling nucleotides one wishes to quantify. This labelled
nucleotide will have the same chromatographic and ionization
behaviour as the nucleotide to be quantified and serves there-
fore as an ideal internal calibrator to account for any ion
suppression observed when analysing complex mixtures such
as bacterial metabolite extracts [41–44]. While such internal
isotope-labelled standards are extremely important for an
accurate quantification of nucleotide levels, they are currently
not commercially available and need to be synthesized by the
user, most often using recombinant cyclase enzymes.
The LC–MS/MS-based method is currently the most
frequently used approach for the detection and quantification
of signalling nucleotides in bacterial extracts, but it requires
highly specialized equipment and expertise. A good alternative
method that requires less specialized equipment and can there-
fore be more easily and routinely performed is an ELISA-based
method. This method is frequently used for the detection of
30,50-cAMP in eukaryotic extracts using commercially available
kits. A modified ELISA approach was recently described for
the quantification of c-di-AMP in bacterial extracts [45].
For this approach, bacterial metabolite extracts are mixed
with a known concentration of biotinylated-c-di-AMP and
applied to a well of a 96-well plate that has been coated with
a c-di-AMP-specific receptor protein (figure 3a). The amount
of the biotinylated-c-di-AMP that binds to the receptor proteins
depends on the concentration of the c-di-AMP in the extract
(figure 3a). The amount of biotinylated-c-di-AMP retained
in the well is subsequently quantified using, for instance,horseradish peroxidase-conjugated streptavidin and an appro-
priate signal detection kit. Based on the signal obtained
compared with that of a simultaneously determined standard
curve, the amount of c-di-AMP contained in bacterial extracts
can be calculated (figure 3a). Performing an ELISA analysis is
relatively inexpensive and fast, thus allowing the processing
of multiple samples in a single run. However, usually only a
single nucleotide is detectedwithin an experiment and a careful
calibration, and standard curve determination is required for
each experiment.
The above-described methods are designed for the
detection and quantification of signalling nucleotides within
large populations of bacterial cells, and are often employed
to measure differences in nucleotide levels after exposing
bacteria to different environmental conditions or between
wild-type and mutant bacteria. Methods that can report on
nucleotide levels directly within living cells and on a single
cell level have also been developed [46–49]. For instance,
transcriptional fusion constructs have been created between
nucleotide-responsive promoter elements and genes coding
for fluorescent proteins [49]. Alternatively, nucleotide-specific
riboswitches have been adapted for the construction of biosen-
sors by coupling them to fluorescence probes or the expression
of fluorescent proteins [47]. In the example depicted in
figure 3b, at a low cellular nucleotide concentration, the
riboswitch will be in the ON state, and bacteria will be
highly fluorescent, but as the cellular nucleotide concentration
increases, the riboswitch will switch to the nucleotide-bound
OFF state, and bacteria will be non- or only dimly fluorescent
(figure 3). Changes in fluorescent signal can be measured
on a population level or in individual cells by fluorescence
microscopy. A second type of biosensor is a fluorescence reson-
ance energy transfer (FRET)-based sensor (figure 3c). For this
sensor, a nucleotide-binding receptor protein is sandwiched
between two fluorescent proteins with suitable excitation and
emission wavelengths, such as a cyan fluorescent protein
(CFP) and a yellow fluorescent protein (YFP). If the fluorescent
proteins are in close enough proximity, one protein can be
excited (in this case CFP) and the energy transferred to the
second protein (in this case YFP) and emission by the second
protein can be detected (figure 3c). In the example shown in
figure 3c, a high FRET signal is observed in bacterial cells
with a low level of signalling nucleotide. When the signalling
nucleotide concentration in the cell increases, the nucleotide
will bind to the sandwiched receptor protein leading to a
conformational change in the receptor protein, placing the
CFP and YFP proteins further apart and decreasing the
FRET signal (figure 3c). The changes in FRET signal and
fluorescence can again be measured on a population level or
in individual cells by a fluorescence microscopy analysis.
c-di-GMP-specific FRET sensors have been used to visualize
changes in nucleotide levels in several Gram-negative bacteria
[46]. For example, a c-di-GMP-specific-FRET sensor was used
to detect the uneven distribution of c-di-GMP between the
flagellated motile cell and the surface-attached stalk cell
that are produced after asymmetric cell division of Caulobacter
crescentus: the stalk cell retained a higher level of c-di-GMP
than the motile daughter cell [46]. A similar asymmetric
c-di-GMP content in daughter cellswas observed following cell
division in the Gram-negative bacterial pathogen P. aeruginosa
[46]. It was subsequently shown that the asymmetric distri-
bution of a c-di-GMP-specific phosphodiesterase enzyme is
responsible for this [50]. Therefore, besides the ability to
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Figure 3. Methods for the detection of signalling nucleotides in bacterial extracts or within living cells. (a) Detection of nucleotides in cell extracts using an ELISA-
based method. (b) Schematic of a riboswitch-based sensor for the detection of a specific signalling nucleotide in living cells. (c) Schematic of a FRET-based sensor for
the detection of a signalling nucleotide in living cells.
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FRET-based biosensors make it possible to follow changes in
nucleotide levels in real time, providing a unique view on the
temporal aspects of nucleotide signalling processes.4. Genome-wide approaches aiding in the
identification of nucleotide receptor proteins
Discovering the receptors of signalling nucleotides is a criti-
cal aspect of understanding the molecular mechanism of
regulation. The first bacterial receptor protein that was ident-
ified was a 30,50-cAMP binding protein identified in E. coli
and called CAP or CRP. It was identified through two different
biochemical fractionation approaches: (i) by restoration of a
biochemical function and (ii) by binding to radiolabelled
30,50-cAMP. For the first approach, a mutant E. coli strain that
produced cAMP but did not produce b-galactosidase in
response to increased cAMP levels was used [51]. By purifying
the activity fromwild-type cells that stimulated the production
of b-galactosidase in the mutant cell lysate, the catabolite-acti-
vating protein (CAP) was isolated [51]. The other approach
identified the 30,50-cAMP receptor protein (referred to as
CRP) by incubating protein fractions derived from a wild-
type E. coli strain with radiolabelled cAMP and identifying
proteins that co-precipitated in an ammonium sulfate precipita-
ted step with the radiolabelled nucleotide [52]. Identification of
CAP/CRP led to a major advance in our understanding oftranscriptional regulation in bacterial cells. These early studies
revealed the importance of the identification of receptor pro-
teins of signalling nucleotides and highlighted the challenges
and difficulties in identifying such receptors.
The initial characterization of a c-di-GMP receptor is also
instructive in understanding the difficulty of receptor discov-
ery for cyclic-di-nucleotides. The Benziman laboratory, which
first characterized c-di-GMP as a signalling molecule that
activates the bacterial cellulose synthase, proposed that a
part of the cellulose synthase complex binds c-di-GMP [27].
Subsequent studies using UV-mediated photolabelling of
radiolabelled c-di-GMP identified BcsB as the part of the cel-
lulose synthase complex that binds c-di-GMP [53]. Later work
however showed that it is actually a different protein of the
complex, namely BcsA, that binds c-di-GMP via its PilZ
domain [54]. Subsequent structural studies revealed that
binding of the nucleotide to BcsA removes the PilZ domain
from the catalytic site of the cellulose synthase [55,56]. The
identification of the PilZ domain allowed a sequence-based
bioinformatics approach to identify a number of other c-di-
GMP receptors. However, PilZ domains were not able to
explain all c-di-GMP-regulated phenotypes in the diverse
set of organisms that used c-di-GMP signalling. In the
past 10 years, several approaches have been employed to
systematically identify c-di-GMP receptors, including UV
cross-linking/mass spectrometry identification, affinity pull-
down and mass spectrometry identification, and screening
through open reading frame libraries (ORFeomes; figure 4).
(a) affinity pulldown/mass spectrometry screen
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Figure 4. Schematic of genome-wide approaches for the identification of receptor proteins. (a) Affinity pull-down/mass spectrometry approach. Bacterial extracts are
applied to a matrix coupled to a specific signalling nucleotide. Most bacterial proteins will pass through the column, whereas specific receptor proteins are retained
on the column. Bound receptor proteins (or complexes) are eluted and subsequently identified by a mass spectrometry approach. (b) DRaCALA-based ORFeome
library screen. E. coli lysate overproducing a specific ORFeom protein are arrayed out in 96-well plates. Lysates are mixed with a radiolabelled nucleotide and a small
aliquot is subsequently spotted onto a nitrocellulose membrane. A positive interaction between an ORFeome protein and the signalling nucleotide is detected when
the radioactive ligand remains bound to the protein in the centre of the spot, whereas in the case of non-interacting proteins, the radioactive ligand will diffuse
outwards along the whole spot.
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is through direct UV cross-linking of radiolabelled nucleo-
tides to such receptors followed by the identification of the
cross-linked polypeptide by tandem mass spectrometry.
This strategy has allowed the identification of additional
c-di-GMP receptor proteins, highlighting that photocross-
linking and subsequent protein identification is a feasible
approach and can lead to the identification of new receptors
[57]. The above-mentioned approach was improved using
modified cyclic dinucleotides coupled to affinity resin,
which allowed for the purification of receptor proteins fol-
lowed by their identification through mass spectrometry
(figure 4a). The cyclic dinucleotide can be coupled to a
biotin tag or directly to the resin through activated groups
[58–60]. In the search for c-di-AMP binding proteins, both
types of affinity resins were used. Biotinylated c-di-AMP
coupled to magnetic streptavidin–agarose beads allowed
the identification of KtrA, a component of the potassium
transporter, in S. aureus [59], whereas in the case of Listeria
monocytogenes, coupling of c-di-AMP to epoxy-activated
sepharose beads lead to the identification of the pyruvate
carboxylase as a c-di-AMP binding protein, PgpH, aphosphodiesterase that linearizes c-di-AMP and several other
receptor proteins [60,61]. A modified form of c-di-GMP with
an extended 20OH linker and a reactive cross-linker can interact
with a diverse set of known binding proteins, indicating that
this type of modification is well tolerated by macromolecular
receptors [58]. Further development of molecules with other
capturing technologies such as click or photoclick moieties
may improve capture and identification of cyclic dinucleotide
interacting proteins.
Another parallel approach for the identification of recep-
tor proteins is to empirically test all open reading frames or
proteins encoded within a bacterial genome for their ability
to bind to a specific nucleotide. In this approach, each protein
is heterologously expressed in E. coli and lysates are gener-
ated (figure 4b). The individual lysates are then tested for
binding to the signalling nucleotide using the differential
radial capillary action of ligand assay (DRaCALA;
figure 4b) [62]. This genome-wide approach has allowed the
identification of several new proteins that interact with
cyclic dinucleotides. For example, a DRaCALA-based screen
of the S. aureus ORFeome library for c-di-AMP and
(p)ppGpp receptors identified PstA and KdpD as c-di-AMP
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small GTPases as novel (p)ppGpp receptors [59,63]. A screen
for c-di-GMP binding proteins from E. coli identified the GIL
domain in BcsE as a receptor and confirmed the binding of
c-di-GMP by a number of known receptors [64]. Two screens
for binding proteins of c-di-GMP and pGpG were performed
with a Vibrio cholerae ORFeome library. The c-di-GMP screen
identified MshE as a receptor, which revealed that a new
family of type II secretion system and type IV pili ATPases
can bind c-di-GMP [65]. The pGpG screen revealed that the
oligoribonuclease Orn binds pGpG [66] and serves as the pri-
mary phosphodiesterase B to break pGpG down into GMP
[66,67]. These results suggest that the DRaCALA-based
screening method can provide a genome-level perspective
of nucleotide binding proteins.
Together, these studies demonstrate that a number of new
approaches can identify receptors of nucleotide signalling
molecules. The two main genome-wide approaches, affinity
pull-down followed by mass spectrometric protein identifi-
cation and DRaCALA-based ORFeome screening (figure 4),
are complementary approaches that enhance discovery of
these important receptors. Each approach has advantages;
the use of nucleotide with functionalized cross-linkers is
broadly applicable and can be used on any bacterium that
may use cyclic dinucleotide signalling pathways. However,
the ability to identify receptor proteins is limited by proteinabundance and the sensitivity of mass spectrometry. None-
theless, improvements in mass spectrometry technology
should enhance the identification of new receptor proteins,
using various affinity resin and capture compounds. The
benefit of DRaCALA-based screens is that protein expression
within the endogenous host does not depend on specific
growth conditions. However, this approach requires the
availability of an ORFeome library for the expression of the
individual proteins in a heterologous host, that a single
gene encodes the receptor protein and that heterologous
expression of the protein is not toxic to E. coli. Future use of
these two complementary methods will most certainly lead
to the discovery of additional receptor proteins that bind
cyclic dinucleotides and other signalling nucleotides, will
enhance our understanding of secondary nucleotide signal-
ling systems and likely reveal novel concepts and signalling
pathways in bacteria.
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